← Leaderboards
Xiang Fang
University Of Texas Med Br Galveston
$1,954,081
Attributed
$3,350,966
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $800K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,350,966 · 3
By mechanism
R61$2,357,370 · 1
K02$557,196 · 1
R21$436,400 · 1
Top collaborators
- Xiaoyong Bao3 shared
- Miguel Pappolla2 shared
Most similar at University Of Texas Med Br Galveston
Same institution · by research overlap
- Xiaoyong Bao$5,313,914
- Matthieu Gagnon$2,140,470
- Rakez Kayed$17,147,270
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposInsightGenesLeadFamilyS DiseaseS Disease TherapeuticSerumOxidative StressMild Cognitive ImpairmentReceptorProteinsSamplingAmyloidPathogenesisDementiaBrainDiagnostic BiomarkerPathway InteractionsMediatingMitochondriaNerve DegenerationBloodPersons
Grant awards (8)
tRNA-derived RNA Fragments (tRF) as Prognostic and Diagnostic Biomarkers for Alzheimerâs Disease$757,374
R61 · FY2025 · AG
tRNA-derived RNA Fragments (tRF) as Prognostic and Diagnostic Biomarkers for Alzheimerâs Disease$799,998
R61 · FY2024 · AG
tRNA-derived RNA Fragments (tRF) as Prognostic and Diagnostic Biomarkers for Alzheimerâs Disease$799,998
R61 · FY2023 · AG
Role of Neuroprotective Indoles in Delaying the Onset of Cognitive Decline$158,200
R21 · FY2022 · AG · contact PI
Role of Neuroprotective Indoles in Delaying the Onset of Cognitive Decline$278,200
R21 · FY2021 · AG · contact PI
The Role of PGC-1aplha in the Pathogenesis of Myotonic Dystrophy Type 1$190,012
K02 · FY2015 · NS · contact PI
The Role of PGC-1aplha in the Pathogenesis of Myotonic Dystrophy Type 1$190,012
K02 · FY2014 · NS · contact PI
The Role of PGC-1aplha in the Pathogenesis of Myotonic Dystrophy Type 1$177,172
K02 · FY2013 · NS · contact PI